Raj Denhoy analyst

Currently out of the existing stock ratings of Raj Denhoy, 18 are a HOLD (8.78%), 187 are a BUY (91.22%).

Raj Denhoy

Work Performance Price Targets & Ratings Chart

Analyst Raj Denhoy, has had 71.23% of price targets met with an average potential upside of 26.28%, reached in 293 days on average. Previously, Raj Denhoy worked at JEFFERIES.

Raj Denhoy has documented 416 price targets and ratings displayed on 31 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on TELA, Tela Bio at 25-Mar-2026.

Wall Street Analyst Raj Denhoy

Analyst best performing recommendations are on IART (INTEGRA LIFESCIENCES HOLDINGS).
The best stock recommendation documented was for ESTA (ESTABLISHMENT LABS HOLDINGS) on 1/8/2021. The price target of $50 was fulfilled within 7 days with a profit of $12.09 (31.89%), with a performance score of 45.56.

Average potential price target upside

ABMD ABIOMED BSX Boston Scientific Corp DXCM DexCom ESTA Establishment Labs Holdings EW Edwards Lifesciences Corp HOLX Hologic IART Integra LifeSciences Holdings LIVN LivaNova PLC LNTH Lantheus Holdings MDT Medtronic PLC MDWD Mediwound Ltd NUVA NuVasive PODD Insulet TFX Teleflex WMGI Wright Medical Group N.V ZBH Zimmer Biomet Holdings ABT Abbott Laboratories SYK Stryker AXGN Axogen RMD ResMed COO The Cooper Companies ATEC Alphatec Holdings STAA STAAR Surgical Company PROF Profound Medical Corp ALGN Align Technology RWLK Rewalk Robotics Ltd TELA Tela Bio ALR Alerislife KMDA Kamada ARAY Accuray

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 18-Jun-2021

$388

$355

4 years 20 days ago
(02-Nov-2022)

2/5 (40%)

$14.49 (3.88%)

88

Sell Since 07-Jan-2022

$380

$235

4 years 20 days ago
(02-Nov-2022)

3/4 (75%)

$6.49 (1.74%)

49

Buy Since 22-Feb-2018

$380

$350

4 years 21 days ago
(01-Nov-2022)

25/44 (56.82%)

$2.18 (0.58%)

141

Buy Since 30-Jun-2021

$300

$425

4 years 1 months 10 days ago
(12-Oct-2022)

1/3 (33.33%)

$57.23 (23.57%)

20

Hold Since 01-May-2020

$325

$375

4 years 9 months 18 days ago
(04-Feb-2022)

20/20 (100%)

$29.35 (9.93%)

85

Show more analysts

Stocks Raj Denhoy covered previously. Scores are shown for active stocks only.

HAE Haemonetics

Please expand the browser size to see the chart

✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?